Suit Accuses Generic Drugmakers Of Overcharging Medicaid

The Associated Press/CBS News: Whistleblower Lawsuit Accuses Generic Drugmakers Of Scheme That Overcharged Medicaid
Three generic drugmakers are being accused in a whistleblower lawsuit of scheming to overcharge the government by tens of millions of dollars for medicines. The U.S. Attorney's office on Tuesday joined in the lawsuit, brought by Chicago pharmacist Bernard Lisitza. His attorneys alleged in a 162-page complaint unsealed Tuesday afternoon that Par Pharmaceuticals Companies Inc. of Woodcliff Lake, N.J., and two foreign generic drugmakers overcharged the Medicaid program by getting pharmacies to dispense different, more-expensive, dosage forms than what was prescribed. ... All three companies have denied wrongdoing (Johnson, 9/6).

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.